BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 25685061)

  • 1. The multifaceted role of CD146/MCAM in the promotion of melanoma progression.
    Lei X; Guan CW; Song Y; Wang H
    Cancer Cell Int; 2015; 15(1):3. PubMed ID: 25685061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MCAM/MUC18/CD146 as a Multifaceted Warning Marker of Melanoma Progression in Liquid Biopsy.
    Rapanotti MC; Cugini E; Nuccetelli M; Terrinoni A; Di Raimondo C; Lombardo P; Costanza G; Cosio T; Rossi P; Orlandi A; Campione E; Bernardini S; Blot-Chabaud M; Bianchi L
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Galectin-3 Is a Natural Binding Ligand of MCAM (CD146, MUC18) in Melanoma Cells and Their Interaction Promotes Melanoma Progression.
    Pang Y; Maxwell E; Sindrewicz-Goral P; Shapanis A; Li S; Morgan M; Yu LG
    Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MUC18/MCAM (CD146), an activation antigen of human T lymphocytes.
    Pickl WF; Majdic O; Fischer GF; Petzelbauer P; Faé I; Waclavicek M; Stöckl J; Scheinecker C; Vidicki T; Aschauer H; Johnson JP; Knapp W
    J Immunol; 1997 Mar; 158(5):2107-15. PubMed ID: 9036955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical Expression of MCAM/CD146 in Canine Melanoma.
    Abou Asa S
    J Comp Pathol; 2017 Jul; 157(1):27-33. PubMed ID: 28735667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minimal Residual Disease in Melanoma:molecular characterization of in transit cutaneous metastases and Circulating Melanoma Cells recognizes an expression panel potentially related to disease progression.
    Rapanotti MC; Viguria TMS; Spallone G; Terrinoni A; Rossi P; Costanza G; Campione E; Lombardo P; Pathirannehalage CD; Orlandi A; Bernardini S; Bianchi L
    Cancer Treat Res Commun; 2020; 25():100262. PubMed ID: 33338742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioimmunotherapy for melanoma using fully human antibodies targeting MCAM/MUC18 and IL-8.
    Melnikova VO; Bar-Eli M
    Pigment Cell Res; 2006 Oct; 19(5):395-405. PubMed ID: 16965268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Galectin-3 interacts with the cell-surface glycoprotein CD146 (MCAM, MUC18) and induces secretion of metastasis-promoting cytokines from vascular endothelial cells.
    Colomb F; Wang W; Simpson D; Zafar M; Beynon R; Rhodes JM; Yu LG
    J Biol Chem; 2017 May; 292(20):8381-8389. PubMed ID: 28364041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential molecular analysis of circulating MCAM/MUC18 expression: a promising disease biomarker related to clinical outcome in melanoma.
    Rapanotti MC; Suarez Viguria TM; Costanza G; Ricozzi I; Pierantozzi A; Di Stefani A; Campione E; Bernardini S; Chimenti S; Orlandi A; Bianchi L
    Arch Dermatol Res; 2014 Aug; 306(6):527-37. PubMed ID: 24902661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunization against MUC18/MCAM, a novel antigen that drives melanoma invasion and metastasis.
    Leslie MC; Zhao YJ; Lachman LB; Hwu P; Wu GJ; Bar-Eli M
    Gene Ther; 2007 Feb; 14(4):316-23. PubMed ID: 17024104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of MUC18/MCAM/CD146 expression on human melanoma growth and metastasis in SCID mice.
    Schlagbauer-Wadl H; Jansen B; Müller M; Polterauer P; Wolff K; Eichler HG; Pehamberger H; Konak E; Johnson JP
    Int J Cancer; 1999 Jun; 81(6):951-5. PubMed ID: 10362144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ectopic expression of MCAM/MUC18 increases in vitro motility and invasiveness, but decreases in vivo tumorigenesis and metastasis of a mouse melanoma K1735-9 subline in a syngeneic mouse model.
    Wu GJ
    Clin Exp Metastasis; 2016 Dec; 33(8):817-828. PubMed ID: 27510563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of MCAM/MUC18 by human melanoma cells leads to increased tumor growth and metastasis.
    Xie S; Luca M; Huang S; Gutman M; Reich R; Johnson JP; Bar-Eli M
    Cancer Res; 1997 Jun; 57(11):2295-303. PubMed ID: 9187135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melanoma-associated adhesion molecule MUC18/MCAM (CD146) and transcriptional regulator mader in normal human CNS.
    Schwarz MJ; Müller N; Körschenhausen D; Kirsch KH; Penning R; Ackenheil M; Johnson JP; Hampel H
    Neuroimmunomodulation; 1998; 5(5):270-6. PubMed ID: 9730695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of Id-1 is regulated by MCAM/MUC18: a missing link in melanoma progression.
    Zigler M; Villares GJ; Dobroff AS; Wang H; Huang L; Braeuer RR; Kamiya T; Melnikova VO; Song R; Friedman R; Alani RM; Bar-Eli M
    Cancer Res; 2011 May; 71(10):3494-504. PubMed ID: 21467165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fully human antibodies to MCAM/MUC18 inhibit tumor growth and metastasis of human melanoma.
    Mills L; Tellez C; Huang S; Baker C; McCarty M; Green L; Gudas JM; Feng X; Bar-Eli M
    Cancer Res; 2002 Sep; 62(17):5106-14. PubMed ID: 12208768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell adhesion molecules in the development and progression of malignant melanoma.
    Johnson JP
    Cancer Metastasis Rev; 1999; 18(3):345-57. PubMed ID: 10721489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Towards understanding the mode of action of the multifaceted cell adhesion receptor CD146.
    Ouhtit A; Gaur RL; Abd Elmageed ZY; Fernando A; Thouta R; Trappey AK; Abdraboh ME; El-Sayyad HI; Rao P; Raj MG
    Biochim Biophys Acta; 2009 Apr; 1795(2):130-6. PubMed ID: 19356677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synovial fluid CD146 (MUC18), a marker for synovial membrane angiogenesis in rheumatoid arthritis.
    Neidhart M; Wehrli R; Brühlmann P; Michel BA; Gay RE; Gay S
    Arthritis Rheum; 1999 Apr; 42(4):622-30. PubMed ID: 10211875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelin-1 upregulates MCAM in melanocytes.
    Mangahas CR; dela Cruz GV; Schneider RJ; Jamal S
    J Invest Dermatol; 2004 Dec; 123(6):1135-9. PubMed ID: 15610525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.